Stocks
Themes
Market Cap Ranking
Trading Strategies
SEC Filings TLDR
Analysis Reports
Sign in
Loading stock data...
Loading updates and signals...
Back
CYCC
$6.37
-5.91%
Analyze
1M
-27.4%
3M
+944.3%
0
Market Cap:
$14.26M
Cyclacel Pharmaceuticals Inc
Healthcare |
Biotechnology
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops drugs for the treatment of cancer and other proliferative diseases. The company is headquartered in Berkeley Heights, New Jersey.
Click "Analyze" to generate stock analysis
CYCC Price Trend and Signals
CYCC Financials
Signals
News
SEC Filings
Holders
Research Reports
AI Analysis
2025-09-11
Somewhat Bearish
price_signal
Monthly low detected.
2025-09-09
Somewhat Bearish
price_signal
Monthly low detected.
2025-09-08
Somewhat Bearish
price_signal
Monthly low detected.
2025-09-05
Somewhat Bearish
price_signal
Monthly low detected.